| Literature DB >> 26677381 |
Rafał Badacz1, Tadeusz Przewłocki2, Izabela Karch1, Piotr Pieniążek2, Agnieszka Rosławiecka1, Szymon Mleczko1, Andrzej Brzychczy3, Mariusz Trystuła3, Krzysztof Żmudka1, Anna Kabłak-Ziembicka1.
Abstract
INTRODUCTION: The circle of Willis is thought to play a key role in development of collateral flow in patients with internal carotid artery stenosis (ICAS). AIM: To assess flow in the circle of Willis in patients with recent ischemic stroke (IS).Entities:
Keywords: carotid artery stenosis; circle of Willis; collateral circulation; stroke; transcranial Doppler
Year: 2015 PMID: 26677381 PMCID: PMC4679799 DOI: 10.5114/pwki.2015.55602
Source DB: PubMed Journal: Postepy Kardiol Interwencyjnej ISSN: 1734-9338 Impact factor: 1.426
Clinical characteristics of respective groups (calculated from Student's t-test and χ2 test)
| Parameter | Group I ( | Group II ( | Value of |
|---|---|---|---|
| Age | 67.6 ±9.5 | 66.0 ±8.9 | 0.050 |
| Male gender | 70 (69%) | 195 (72%) | 0.460 |
| HT | 96 (94%) | 250 (93%) | 0.685 |
| DM | 32 (31%) | 93 (35%) | 0.560 |
| Hyperlipidemia | 84 (82%) | 246 (91%) | 0.125 |
| Cigarette smoking | 65 (64%) | 198 (74%) | 0.061 |
| Ischemic heart disease | 55 (54%) | 162 (60%) | 0.271 |
| Myocardial infarction | 19 (19%) | 93 (35%) | 0.003 |
| Grade of ICAS | 85 ±9.6% | 83 ±9.4% | 0.089 |
Significant coronary artery stenosis exceeding 50% lumen reduction on coronary angiography,
according to NASCET criteria [7].
Peak systolic (PSV) and end-diastolic (EDV) flow velocities in ipsilateral MCA, ACA, and PCA in neurologically symptomatic patients (group I) vs. asymptomatic patients (group II)
| Velocity [cm/s] | Group I ( | Group II ( | Mann-Whitney |
|---|---|---|---|
| MCA: | |||
| PSV | 65 ±15 | 71 ±20 | 0.015 |
| EDV | 31 ±8 | 31 ±12 | 0.761 |
| ACA: | |||
| PSV | 71 ±24 | 86 ±34 | < 0.001 |
| EDV | 32 ±12 | 37 ±17 | 0.038 |
| PCA: | |||
| PSV | 60 ±18 | 63 ±23 | 0.431 |
| EDV | 27 ±12 | 27 ±11 | 0.554 |
*Value of p is given for PSV.
Frequency of functional collateral circulation through ACoA or PCoA or both in neurologically symptomatic patients (group I) vs. asymptomatic patients (group II)
| Variable | Group I ( | Group II ( | χ2 Value of |
|---|---|---|---|
| ACoA: | |||
| Present | 55 (54%) | 211 (78%) | < 0.001 |
| Absent | 47 (46%) | 58 (22%) | |
| PCoA: | |||
| Present | 20 (20%) | 113 (42%) | < 0.001 |
| Absent | 82 (80%) | 156 (58%) | |
| ACoA and/or PCoA: | |||
| Present | 68 (67%) | 231 (86%) | < 0.001 |
| Absent | 34 (33%) | 38 (14%) |
Independent predictors of ischemic stroke
| Variable | RR (95% CI) | Value of |
|---|---|---|
| Presence of ACoA | 0.28 (0.16–0.49) | < 0.001 |
| Presence of PCoA | 0.28 (0.15–0.52) | < 0.001 |
| MCA, PSV | 0.97 (0.96–0.99) | < 0.001 |
| ACA, PSV | 0.99 (0.98–0.99) | 0.032 |
| Previous myocardial infarction | 0.37 (0.20–0.70) | 0.002 |
Figure 1Receiver–operator characteristic (ROC) curves showed no good cut-off values for PSV in MCA or ACA to discriminate increased risk of IS